Table 1.
Characteristics of the Study Patients at the Initiation of ART (N = 566)
| Characteristics | |
| Age (years), Mean (SD) | 36.1 ± 9.7 |
| Age group, n (%) | |
| 18–29 years | 156 (27.6) |
| 30–39 years | 197 (34.8) |
| 40–49 years | 165 (29.2) |
| ≥50 years | 48 (8.5) |
| Gender, n (%) | |
| Male | 242 (42.8) |
| Female | 324 (57.2) |
| Residence, n (%) | |
| Urban | 356 (62.9) |
| Rural | 210 (37.1) |
| Education, n (%) | |
| <High school | 452 (79.9) |
| ≥High school | 114 (20.1) |
| WHO stage, n (%) | |
| Stage I/II | 439 (77.6) |
| Stage III/IV | 127 (22.4) |
| CD4+ cell (cells/mm3), Median (IQR) | 264 (192–500) |
| <200 | 160 (28.3) |
| ≥200 | 406 (71.7) |
| Opportunistic infections, n (%) | |
| Yes | 149 (26.3) |
| No | 417 (73.7) |
| Body mass index (kg/m2), Mean (SD) | 20.4 ± 3.6 |
| Estimated glomerular filtration rate (mL/min/1.73m2), Mean (SD) | 99.2 ± 58.2 |
| Hemoglobin (g/dl), Mean (SD) | 12.7 ± 2.7 |
| Total white blood cell count (×103 cell/μL), Median (IQR) | 5.7 (4.5–7.5) |
| Platelet count (×103 cell/μL), Median (IQR) | 240 (176–305) |